Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jackson

Showing results (741-750 of 1,462) with videos related to

Pageof 147
Sort By:
Cancer Research|November 14, 1997
A precise interchromosomal reciprocal exchange between hot spots for cleavable complex formation by topoisomerase II in amsacrine-treated Chinese hamster ovary cellsR H Zhou, P Wang, Y Zou, et al.
Cancers|May 13, 2023
Extracellular Vesicles Potentiate Medulloblastoma Metastasis in an EMMPRIN and MMP-2 Dependent MannerHannah K Jackson, Christine Mitoko, Franziska Linke, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Guanine nucleotide-binding inhibitory protein-mediated inhibition of adenylyl cyclase is enhanced in spontaneously hypertensive rat preglomerular arteriolar smooth muscle cellsS J Vyas, R Mokkapatti, R K Dubey, et al.
American Heart Journal|February 1, 1992
The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injuryE D Norton, E K Jackson, M B Turner, et al.
British Journal of Anaesthesia|April 1, 1989
A new microprocessor-controlled anaesthetic machineM K Sykes, B R Sugg, C E Hahn, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failureD P Begany, J A Carcillo, W A Herzer, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
Treatment with the type IV phosphodiesterase inhibitor Ro 20-1724 protects renal and mesenteric blood flow in endotoxemic rats treated with norepinephrineJ A Carcillo, W A Herzer, Z Mi, et al.
Cell Cycle (Georgetown, Tex.)|March 16, 2007
Translational unmasking of Emi2 directs cytostatic factor arrest in meiosis IIJeffrey J Tung, Kiran Padmanabhan, David V Hansen, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2000
Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrineN J Thomas, J A Carcillo, W A Herzer, et al.
Obesity Research|June 25, 2005
Extracellular cyclic AMP-adenosine pathway in isolated adipocytes and adipose tissueMarci B Strouch, Edwin K Jackson, Zaichuan Mi, et al.
Pageof 147

Showing results (741-750 of 1,462) with videos related to

Sort By:
Pageof 147
Cancer Research|November 14, 1997
A precise interchromosomal reciprocal exchange between hot spots for cleavable complex formation by topoisomerase II in amsacrine-treated Chinese hamster ovary cellsR H Zhou, P Wang, Y Zou, et al.
Cancers|May 13, 2023
Extracellular Vesicles Potentiate Medulloblastoma Metastasis in an EMMPRIN and MMP-2 Dependent MannerHannah K Jackson, Christine Mitoko, Franziska Linke, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Guanine nucleotide-binding inhibitory protein-mediated inhibition of adenylyl cyclase is enhanced in spontaneously hypertensive rat preglomerular arteriolar smooth muscle cellsS J Vyas, R Mokkapatti, R K Dubey, et al.
American Heart Journal|February 1, 1992
The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injuryE D Norton, E K Jackson, M B Turner, et al.
British Journal of Anaesthesia|April 1, 1989
A new microprocessor-controlled anaesthetic machineM K Sykes, B R Sugg, C E Hahn, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failureD P Begany, J A Carcillo, W A Herzer, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
Treatment with the type IV phosphodiesterase inhibitor Ro 20-1724 protects renal and mesenteric blood flow in endotoxemic rats treated with norepinephrineJ A Carcillo, W A Herzer, Z Mi, et al.
Cell Cycle (Georgetown, Tex.)|March 16, 2007
Translational unmasking of Emi2 directs cytostatic factor arrest in meiosis IIJeffrey J Tung, Kiran Padmanabhan, David V Hansen, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2000
Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrineN J Thomas, J A Carcillo, W A Herzer, et al.
Obesity Research|June 25, 2005
Extracellular cyclic AMP-adenosine pathway in isolated adipocytes and adipose tissueMarci B Strouch, Edwin K Jackson, Zaichuan Mi, et al.
Pageof 147